$SAGE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sage Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sage Therapeutics, Inc.. Get notifications about new insider transactions in Sage Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 73.89 | 4,945 | 365,403 | 221,277 | 226.2 K to 221.3 K (-2.19 %) |
Jun 01 2015 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | A | 73.13 | 13,922 | 1,018,116 | 13,922 | |
May 29 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 73.13 | 13,922 | 1,018,116 | 13,922 | ||
May 29 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Option Exercise | A | 73.13 | 13,922 | 1,018,116 | 13,922 | ||
May 29 2015 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 73.13 | 13,922 | 1,018,116 | 13,922 | ||
May 29 2015 | SAGE | Sage Therapeutics, ... | PIEN HOWARD H | Option Exercise | A | 73.13 | 13,922 | 1,018,116 | 13,922 | ||
May 29 2015 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Option Exercise | A | 73.13 | 13,922 | 1,018,116 | 13,922 | ||
May 05 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Director | Sell | S | 53.31 | 20,000 | 1,066,200 | 763,650 | 783.7 K to 763.7 K (-2.55 %) |
Apr 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 48.51 | 20,000 | 970,200 | 783,650 | 803.7 K to 783.7 K (-2.49 %) | |
Mar 27 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 51.49 | 5,400 | 278,046 | 46,948 | 52.3 K to 46.9 K (-10.32 %) |
Feb 27 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 42.05 | 6,000 | 252,300 | 52,348 | 58.3 K to 52.3 K (-10.28 %) |
Jan 28 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 81,094 | 0 | 0 | 81.1 K to 0 (-100.00 %) |
Jan 28 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 81,094 | 0 | 81,094 | 0 to 81.1 K |
Jan 28 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,255,177 | 0 | 9,773,073 | 11 M to 9.8 M (-11.38 %) |
Jan 28 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 11,804 | 0 | 17,928 | 6.1 K to 17.9 K (+192.75 %) |
Jan 28 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 81,094 | 0 | 0 | 81.1 K to 0 (-100.00 %) |
Jan 28 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 81,094 | 0 | 81,094 | 0 to 81.1 K |
Jan 28 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,255,177 | 0 | 9,773,073 | 11 M to 9.8 M (-11.38 %) |
Jan 27 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President and CEO | Option Exercise | A | 38.25 | 324,000 | 12,393,000 | 324,000 | |
Jan 27 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 38.25 | 68,000 | 2,601,000 | 68,000 | |
Jan 27 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 37.29 | 6,000 | 223,717 | 58,348 | 64.3 K to 58.3 K (-9.32 %) |
Jan 27 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Option Exercise | A | 38.25 | 59,500 | 2,275,875 | 59,500 | |
Jan 27 2015 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Option Exercise | A | 38.25 | 68,000 | 2,601,000 | 68,000 | |
Jan 27 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 38.25 | 51,000 | 1,950,750 | 51,000 | |
Jan 20 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 42,173 | 0 | 0 | 42.2 K to 0 (-100.00 %) |
Jan 20 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 42,173 | 0 | 42,173 | 0 to 42.2 K |
Jan 20 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 652,758 | 0 | 11,028,250 | 11.7 M to 11 M (-5.59 %) |
Jan 20 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 6,124 | 0 | 6,124 | 0 to 6.1 K |
Jan 20 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 42,173 | 0 | 0 | 42.2 K to 0 (-100.00 %) |
Jan 20 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 42,173 | 0 | 42,173 | 0 to 42.2 K |
Jan 20 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 652,758 | 0 | 11,028,250 | 11.7 M to 11 M (-5.59 %) |
Jan 16 2015 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 6,135 | 0 | 6,135 | 0 to 6.1 K |
Jan 16 2015 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 1,062,345 | 0 | 3,187,044 | 4.2 M to 3.2 M (-25.00 %) |
Jan 16 2015 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Sell | J | 0.00 | 1,062,345 | 0 | 3,187,044 | 4.2 M to 3.2 M (-25.00 %) |
Sep 12 2014 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Director | Option Exercise | A | 29.80 | 20,883 | 622,313 | 20,883 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | See Remarks | Buy | P | 18.00 | 6,000 | 108,000 | 98,063 | 92.1 K to 98.1 K (+6.52 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 885,583 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 281,137 | 0 | 4,249,389 | 4 M to 4.2 M (+7.08 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 2,380,951 | 0 | 3,968,252 | 1.6 M to 4 M (+150.00 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 1,587,301 | 0 | 1,587,301 | 0 to 1.6 M |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Director | Buy | P | 18.00 | 10,000 | 180,000 | 803,650 | 793.7 K to 803.7 K (+1.26 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | P | 18.00 | 4,000 | 72,000 | 226,222 | 222.2 K to 226.2 K (+1.80 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Buy | P | 18.00 | 6,000 | 108,000 | 6,000 | 0 to 6 K |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | P | 18.00 | 6,000 | 108,000 | 6,000 | 0 to 6 K |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 885,583 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 281,137 | 0 | 4,249,389 | 4 M to 4.2 M (+7.08 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 2,380,951 | 0 | 3,968,252 | 1.6 M to 4 M (+150.00 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 1,587,301 | 0 | 1,587,301 | 0 to 1.6 M |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 295,194 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,499,999 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 32,500,000 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 93,712 | 0 | 11,681,008 | 11.6 M to 11.7 M (+0.81 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 793,650 | 0 | 11,587,296 | 10.8 M to 11.6 M (+7.35 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 10,317,457 | 0 | 10,793,646 | 476.2 K to 10.8 M (+2,166.67 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 295,194 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 2,499,999 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 32,500,000 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | C | 0.00 | 93,712 | 0 | 11,681,008 | 11.6 M to 11.7 M (+0.81 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | C | 0.00 | 793,650 | 0 | 11,587,296 | 10.8 M to 11.6 M (+7.35 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | C | 0.00 | 10,317,457 | 0 | 10,793,646 | 476.2 K to 10.8 M (+2,166.67 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Director | Buy | P | 18.00 | 5,000 | 90,000 | 5,000 | 0 to 5 K |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Buy | P | 18.00 | 3,000 | 54,000 | 3,000 | 0 to 3 K |